MPAL
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Immune-targeted Combination With Chemotherapy for Acute Leukemia of Ambiguous Lineage (NCT06991920) | Institute of Hematology & Blood Diseases Hospital, China | 2026-06-30 |
Track MPAL automatically
Every clearance here is in the API, with alerts when new ones post.